Skip to main content
Back to Andreessen Horowitz

Andreessen Horowitz's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Andreessen Horowitz. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$470.1M

Pharmaceutical Portfolio Companies (5)

Export
BiotechnologyGeneticsPharmaceutical

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.

San Francisco, United States
August 2023
$26.0M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Big DataBiotechnologyHealth CarePharmaceutical

Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.

Palo Alto, United States
July 2021
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

New York, United States
June 2024
$372.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Waltham, United States
April 2023
$150K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Cambridge, United States
September 2023
$72.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Andreessen Horowitz's Full Portfolio

View all companies funded by Andreessen Horowitz across every industry and funding stage.

View Full Andreessen Horowitz Portfolio